$0.03
arrow_drop_down9.72%Key Stats | |
---|---|
Open | $0.03 |
Prev. Close | $0.03 |
EPS | -6.57 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
Market Cap | $0.00 |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 0.03 | 0.03 |
52 Week Range | 0.01 | 0.14 |
Ratios | |
---|---|
Revenue | - |
EBITDA Margin % | - |
EPS | -6.57 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Aclarion to Participate in the 2024 Maxim Healthcare Virtual Summit
Aclarion Provides Corporate Update on Nociscan AI Technology Milestones
Aclarion Announces Initial Payer Coverage of Nociscan by AXA Throughout Greater London, UK
Aclarion Expands Commercial Engagement With The London Clinic to Grow Access to Nociscan Throughout Greater London
Aclarion’s Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back Pain
Aclarion Announces Closing of $3.0 Million Public Offering